Raymond James Trust N.A. Sells 197 Shares of Colgate-Palmolive (NYSE:CL)

Raymond James Trust N.A. reduced its position in Colgate-Palmolive (NYSE:CL) by 0.8% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 25,253 shares of the company’s stock after selling 197 shares during the period. Raymond James Trust N.A.’s holdings in Colgate-Palmolive were worth $2,622,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in CL. E Fund Management Hong Kong Co. Ltd. bought a new stake in Colgate-Palmolive during the 2nd quarter valued at $25,000. Continuum Advisory LLC boosted its position in Colgate-Palmolive by 46.5% during the second quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock valued at $38,000 after purchasing an additional 125 shares in the last quarter. Reston Wealth Management LLC purchased a new position in Colgate-Palmolive in the third quarter valued at about $42,000. Capital Performance Advisors LLP bought a new position in Colgate-Palmolive in the third quarter worth about $53,000. Finally, Prospera Private Wealth LLC bought a new stake in shares of Colgate-Palmolive in the 3rd quarter valued at about $64,000. 80.41% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Stock Up 0.7 %

Shares of CL opened at $94.92 on Friday. The company has a market capitalization of $77.55 billion, a price-to-earnings ratio of 27.20, a PEG ratio of 3.36 and a beta of 0.42. Colgate-Palmolive has a 52 week low of $75.50 and a 52 week high of $109.30. The stock’s 50-day moving average price is $98.10 and its 200-day moving average price is $98.54. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were paid a dividend of $0.50 per share. The ex-dividend date was Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.11%. Colgate-Palmolive’s payout ratio is 57.31%.

Wall Street Analyst Weigh In

Several research firms recently commented on CL. StockNews.com upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research note on Thursday, November 14th. Sanford C. Bernstein upped their price target on Colgate-Palmolive from $100.00 to $103.00 and gave the stock a “market perform” rating in a research report on Tuesday, July 30th. Barclays raised their price objective on Colgate-Palmolive from $91.00 to $96.00 and gave the stock an “equal weight” rating in a research report on Monday, July 29th. JPMorgan Chase & Co. upped their target price on Colgate-Palmolive from $113.00 to $114.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. Finally, Morgan Stanley raised their price target on Colgate-Palmolive from $103.00 to $111.00 and gave the stock an “overweight” rating in a report on Monday, July 29th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $105.11.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.